Oppenheimer Raises Xylem (NYSE:XYL) Price Target to $147.00

Xylem (NYSE:XYL) had its price objective hoisted by Oppenheimer from $142.00 to $147.00 in a research report sent to investors on Friday morning, Benzinga reports. The brokerage currently has an outperform rating on the industrial products company’s stock.

Other analysts also recently issued reports about the company. Royal Bank of Canada raised their target price on Xylem from $140.00 to $145.00 and gave the stock an outperform rating in a research note on Wednesday, February 7th. Raymond James raised shares of Xylem from an underperform rating to a market perform rating in a research note on Thursday, January 4th. Robert W. Baird increased their price target on shares of Xylem from $151.00 to $155.00 and gave the company an outperform rating in a research note on Friday. Stifel Nicolaus raised their price target on shares of Xylem from $136.00 to $150.00 and gave the stock a buy rating in a report on Wednesday, February 7th. Finally, BNP Paribas initiated coverage on Xylem in a research report on Tuesday, March 12th. They issued an outperform rating and a $150.00 price objective for the company. Five analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of Moderate Buy and a consensus price target of $140.70.

Xylem Stock Performance

NYSE:XYL opened at $139.21 on Friday. Xylem has a twelve month low of $87.59 and a twelve month high of $139.21. The company has a market cap of $33.75 billion, a P/E ratio of 49.54, a P/E/G ratio of 2.67 and a beta of 1.08. The company has a current ratio of 1.67, a quick ratio of 1.22 and a debt-to-equity ratio of 0.19. The company’s 50-day moving average price is $128.91 and its 200-day moving average price is $115.87.

Xylem (NYSE:XYL) last released its earnings results on Thursday, May 2nd. The industrial products company reported $0.90 earnings per share for the quarter, topping analysts’ consensus estimates of $0.84 by $0.06. The business had revenue of $2.03 billion for the quarter, compared to analyst estimates of $2 billion. Xylem had a net margin of 8.34% and a return on equity of 8.95%. The business’s revenue was up 40.4% on a year-over-year basis. During the same period last year, the company posted $0.72 EPS. On average, sell-side analysts forecast that Xylem will post 4.24 earnings per share for the current fiscal year.

Insider Transactions at Xylem

In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total transaction of $122,890.00. Following the sale, the chief accounting officer now directly owns 2,935 shares of the company’s stock, valued at approximately $360,682.15. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Xylem news, SVP Franz Cerwinka sold 2,408 shares of Xylem stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $121.79, for a total transaction of $293,270.32. Following the completion of the sale, the senior vice president now directly owns 11,750 shares of the company’s stock, valued at approximately $1,431,032.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total value of $122,890.00. Following the sale, the chief accounting officer now owns 2,935 shares of the company’s stock, valued at approximately $360,682.15. The disclosure for this sale can be found here. Company insiders own 0.27% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Bruce G. Allen Investments LLC purchased a new stake in shares of Xylem in the 4th quarter valued at about $27,000. FinTrust Capital Advisors LLC lifted its holdings in shares of Xylem by 170.9% during the first quarter. FinTrust Capital Advisors LLC now owns 317 shares of the industrial products company’s stock worth $41,000 after purchasing an additional 200 shares during the period. Hazlett Burt & Watson Inc. lifted its stake in shares of Xylem by 184.9% in the 1st quarter. Hazlett Burt & Watson Inc. now owns 339 shares of the industrial products company’s stock worth $43,000 after acquiring an additional 220 shares during the period. NBC Securities Inc. purchased a new stake in Xylem in the 3rd quarter valued at approximately $38,000. Finally, Spire Wealth Management grew its holdings in Xylem by 370.9% during the fourth quarter. Spire Wealth Management now owns 485 shares of the industrial products company’s stock worth $54,000 after acquiring an additional 382 shares during the period. 87.96% of the stock is owned by hedge funds and other institutional investors.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.